These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 34117603)
1. Co-expression of transcription factor AP-2beta (TFAP2B) and GATA3 in human mammary epithelial cells with intense, apicobasal immunoreactivity for CK8/18. Raap M; Gierendt L; Werlein C; Kuehnle E; Kreipe HH; Christgen M J Mol Histol; 2021 Dec; 52(6):1257-1264. PubMed ID: 34117603 [TBL] [Abstract][Full Text] [Related]
2. Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β. Raap M; Gronewold M; Christgen H; Glage S; Bentires-Alj M; Koren S; Derksen PW; Boelens M; Jonkers J; Lehmann U; Feuerhake F; Kuehnle E; Gluz O; Kates R; Nitz U; Harbeck N; Kreipe HH; Christgen M Lab Invest; 2018 Jan; 98(1):117-129. PubMed ID: 29035379 [TBL] [Abstract][Full Text] [Related]
3. The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer. Hosseinzadeh L; Kikhtyak Z; Laven-Law G; Pederson SM; Puiu CG; D'Santos CS; Lim E; Carroll JS; Tilley WD; Dwyer AR; Hickey TE Genome Biol; 2024 Feb; 25(1):44. PubMed ID: 38317241 [TBL] [Abstract][Full Text] [Related]
4. Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells. Emmanuel N; Lofgren KA; Peterson EA; Meier DR; Jung EH; Kenny PA Anticancer Res; 2018 Aug; 38(8):4435-4441. PubMed ID: 30061207 [TBL] [Abstract][Full Text] [Related]
5. Androgen Receptor Signalling Promotes a Luminal Phenotype in Mammary Epithelial Cells. Tarulli GA; Laven-Law G; Shehata M; Walters KA; Denis IM; Rahman MM; Handelsman DJ; Dean NR; Tilley WD; Hickey TE J Mammary Gland Biol Neoplasia; 2019 Mar; 24(1):99-108. PubMed ID: 30099649 [TBL] [Abstract][Full Text] [Related]
6. AP-2β Is a Downstream Effector of PITX2 Required to Specify Endothelium and Establish Angiogenic Privilege During Corneal Development. Chen L; Martino V; Dombkowski A; Williams T; West-Mays J; Gage PJ Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1072-81. PubMed ID: 26968737 [TBL] [Abstract][Full Text] [Related]
7. Loss of function of GATA3 induces basal-like mammary tumors. Bai F; Zheng C; Liu X; Chan HL; Liu S; Ma J; Ren S; Zhu WG; Pei XH Theranostics; 2022; 12(2):720-733. PubMed ID: 34976209 [No Abstract] [Full Text] [Related]
8. Transcription factor AP-2beta in development, differentiation and tumorigenesis. Raap M; Gierendt L; Kreipe HH; Christgen M Int J Cancer; 2021 Sep; 149(6):1221-1227. PubMed ID: 33720400 [TBL] [Abstract][Full Text] [Related]
9. Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer. Cohen H; Ben-Hamo R; Gidoni M; Yitzhaki I; Kozol R; Zilberberg A; Efroni S Breast Cancer Res; 2014 Nov; 16(6):464. PubMed ID: 25410484 [TBL] [Abstract][Full Text] [Related]
10. Expression of androgen receptor and its association with estrogen receptor and androgen receptor downstream proteins in normal/benign breast luminal epithelium. Wang X; Yarid N; McMahon L; Yang Q; Hicks DG Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):498-504. PubMed ID: 24897063 [TBL] [Abstract][Full Text] [Related]
11. Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity. Chamberlin T; D'Amato JV; Arendt LM Breast Cancer Res; 2017 Nov; 19(1):128. PubMed ID: 29187227 [TBL] [Abstract][Full Text] [Related]
12. Impact of immunohistochemistry-based subtyping of GATA3, CK20, CK5/6, and CK14 expression on survival after radical cystectomy for muscle-invasive bladder cancer. Bejrananda T; Kanjanapradit K; Saetang J; Sangkhathat S Sci Rep; 2021 Oct; 11(1):21186. PubMed ID: 34707176 [TBL] [Abstract][Full Text] [Related]
13. Arsenic reduces the GATA3 expression associated with an increase in proliferation and migration of mammary epithelial cell line MCF-10A. Vergara-Gerónimo CA; León-Del-Rio A; Rodríguez-Dorantes M; Camacho-Carranza R; Ostrosky-Wegman P; Salazar AM Toxicol Appl Pharmacol; 2023 Aug; 472():116573. PubMed ID: 37269932 [TBL] [Abstract][Full Text] [Related]
14. GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas. Cakir A; Isik Gonul I; Ekinci O; Cetin B; Benekli M; Uluoglu O Pathol Res Pract; 2017 Mar; 213(3):227-234. PubMed ID: 28215639 [TBL] [Abstract][Full Text] [Related]
15. Conditional Deletion of AP-2β in the Periocular Mesenchyme of Mice Alters Corneal Epithelial Cell Fate and Stratification. Walker H; Taiyab A; Deschamps P; Williams T; West-Mays JA Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445433 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland. Shehata M; Teschendorff A; Sharp G; Novcic N; Russell IA; Avril S; Prater M; Eirew P; Caldas C; Watson CJ; Stingl J Breast Cancer Res; 2012 Oct; 14(5):R134. PubMed ID: 23088371 [TBL] [Abstract][Full Text] [Related]
17. Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis. Liu X; Bai F; Wang Y; Wang C; Chan HL; Zheng C; Fang J; Zhu WG; Pei XH Cell Death Dis; 2023 Jun; 14(6):370. PubMed ID: 37353480 [TBL] [Abstract][Full Text] [Related]
18. IPH-926 lobular breast cancer cells are triple-negative but their microarray profile uncovers a luminal subtype. Christgen M; Geffers R; Kreipe H; Lehmann U Cancer Sci; 2013 Dec; 104(12):1726-30. PubMed ID: 24344720 [TBL] [Abstract][Full Text] [Related]
19. The impact of the effectiveness of GATA3 as a prognostic factor in breast cancer. Fararjeh AS; Tu SH; Chen LC; Liu YR; Lin YK; Chang HL; Chang HW; Wu CH; Hwang-Verslues WW; Ho YS Hum Pathol; 2018 Oct; 80():219-230. PubMed ID: 29902578 [TBL] [Abstract][Full Text] [Related]